{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:52:31Z","timestamp":1776779551896,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00259-025-07699-w","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:59:35Z","timestamp":1765259975000},"page":"3056-3063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PSMA PET\/CT for the detection of prostate cancer biochemical recurrence after primary radiation therapy: is it time to review the Phoenix criteria?"],"prefix":"10.1007","volume":"53","author":[{"given":"Laura","family":"Evangelista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-4367","authenticated-orcid":false,"given":"Priscilla","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Jandric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Brignoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Marenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Di Cristina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"7699_CR1","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Prostate Cancer Version 1.2025 \u2014 December 4, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"7699_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","volume":"16","author":"A Zapatero","year":"2015","unstructured":"Zapatero A, Guerrero A, Maldonado X, Alvarez A, Segundo CGS, Rodr\u00edguez MAC, et al. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): a randomised, controlled, phase 3 trial. Lancet Oncol. 2015;16:320\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(15)70045-8.","journal-title":"Lancet Oncol"},{"key":"7699_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach","year":"2006","unstructured":"Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006;65:965\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7699_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-025-02799-x","author":"R Aizawa","year":"2025","unstructured":"Aizawa R, Mizowaki T. Narrative review of focal boost to intraprostatic dominant lesion in intensity-modulated radiation therapy for localized or locally advanced prostate cancer. Int J Clin Oncol. 2025. https:\/\/doi.org\/10.1007\/s10147-025-02799-x.","journal-title":"Int J Clin Oncol"},{"key":"7699_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50:1466\u201386. https:\/\/doi.org\/10.1007\/s00259-022-06089-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7699_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40336-023-00543-x","volume":"11","author":"E Gomis Sell\u00e9s","year":"2023","unstructured":"Gomis Sell\u00e9s E, Maldonado A, Trivi\u00f1o-Iba\u00f1ez E-M, Linares Mesa NA, Sanmamed Salgado N, del Castillo Acu\u00f1a R, et al. PSMA PET\/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria? Clin Transl Imaging. 2023;11:241\u201354. https:\/\/doi.org\/10.1007\/s40336-023-00543-x.","journal-title":"Clin Transl Imaging"},{"key":"7699_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.euo.2024.09.015","volume":"8","author":"EJE van Altena","year":"2025","unstructured":"van Altena EJE, Jansen BHE, Korbee ML, Knol RJJ, Luining WI, Nieuwenhuijzen JA, et al. Prostate-specific membrane antigen positron emission tomography before reaching the Phoenix criteria for biochemical recurrence of prostate cancer after radiotherapy: earlier detection of recurrences. Eur Urol Oncol. 2025;8:417\u201324. https:\/\/doi.org\/10.1016\/j.euo.2024.09.015.","journal-title":"Eur Urol Oncol"},{"key":"7699_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\/CT. J Nucl Med. 2018;59:469\u201378. https:\/\/doi.org\/10.2967\/jnumed.117.198119.","journal-title":"J Nucl Med"},{"key":"7699_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8\u201310. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8.","journal-title":"J Clin Oncol"},{"key":"7699_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17:1047\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(16)30102-4.","journal-title":"Lancet Oncol"},{"key":"7699_CR11","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1200\/JCO.23.02445","volume":"42","author":"WR Lee","year":"2024","unstructured":"Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, et al. Long-term analysis of NRG oncology RTOG 0415: a randomized phase III noninferiority study comparing two fractionation schedules in patients with low-risk prostate cancer. J Clin Oncol. 2024;42:2377\u201381. https:\/\/doi.org\/10.1200\/JCO.23.02445.","journal-title":"J Clin Oncol"},{"key":"7699_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","volume":"391","author":"N van As","year":"2024","unstructured":"van As N, Griffin C, Tree A, Patel J, Ostler P, van der Voet H, et al. Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer. N Engl J Med. 2024;391:1413\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2403365.","journal-title":"N Engl J Med"},{"key":"7699_CR13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549\u201357. https:\/\/doi.org\/10.1016\/S0022-5347(17)36966-5.","journal-title":"J Urol"},{"key":"7699_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.radonc.2018.01.014","volume":"127","author":"C Salembier","year":"2018","unstructured":"Salembier C, Villeirs G, De Bari B, Hoskin P, Pieters BR, Van Vulpen M, et al. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiother Oncol. 2018;127:49\u201361. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.014.","journal-title":"Radiother Oncol"},{"key":"7699_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","volume":"109","author":"WA Hall","year":"2021","unstructured":"Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, et al. NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer. Int J Radiat Oncol Biol Phys. 2021;109:174\u201385. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7699_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/bju.13616","volume":"118","author":"G Meredith","year":"2016","unstructured":"Meredith G, Wong D, Yaxley J, Coughlin G, Thompson L, Kua B, et al. The use of 68 Ga- <scp>PSMA PET CT<\/scp>in men with biochemical recurrence after definitive treatment of acinar prostate cancer. BJU Int. 2016;118:49\u201355. https:\/\/doi.org\/10.1111\/bju.13616.","journal-title":"BJU Int"},{"key":"7699_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41391-019-0163-0","volume":"22","author":"S Raveenthiran","year":"2019","unstructured":"Raveenthiran S, Yaxley J, Gianduzzo T, Kua B, McEwan L, Wong D, et al. The use of 68Ga-PET\/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy. Prostate Cancer Prostatic Dis. 2019;22:385\u201390. https:\/\/doi.org\/10.1038\/s41391-019-0163-0.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"7699_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.euo.2020.01.002","volume":"4","author":"BHE Jansen","year":"2021","unstructured":"Jansen BHE, van Leeuwen PJ, Wondergem M, van der Sluis TM, Nieuwenhuijzen JA, Knol RJJ, et al. Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical recurrence after curative radiotherapy. Eur Urol Oncol. 2021;4:821\u20135. https:\/\/doi.org\/10.1016\/j.euo.2020.01.002.","journal-title":"Eur Urol Oncol"},{"key":"7699_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.2967\/jnumed.121.262861","volume":"63","author":"H Ilhan","year":"2022","unstructured":"Ilhan H, Kroenke M, Wurzer A, Unterrainer M, Heck M, Belka C, et al. 18 f-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after curative-intent radiation therapy: a bicentric retrospective study. J Nucl Med. 2022;63:1208\u201314. https:\/\/doi.org\/10.2967\/jnumed.121.262861.","journal-title":"J Nucl Med"},{"key":"7699_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.radonc.2022.02.014","volume":"169","author":"P Maitre","year":"2022","unstructured":"Maitre P, Sood S, Pathare P, Krishnatry R, Agrawal A, Rangarajan V, et al. Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: implications for potential salvage. Radiother Oncol. 2022;169:71\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2022.02.014.","journal-title":"Radiother Oncol"},{"key":"7699_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.acra.2023.08.044","volume":"31","author":"Q Wu","year":"2024","unstructured":"Wu Q, Bates A, Guntur P, Shamim SA, Nabi G. Detection rate of PSMA PET using different ligands in men with biochemical recurrent prostate cancer following radical treatment: a systematic review and meta-analysis of prospective studies. Acad Radiol. 2024;31:544\u201363. https:\/\/doi.org\/10.1016\/j.acra.2023.08.044.","journal-title":"Acad Radiol"},{"key":"7699_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","volume":"27","author":"S Huang","year":"2024","unstructured":"Huang S, Ong S, McKenzie D, Mirabelli A, Chen DC, Chengodu T, et al. Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer\u2014a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024;27:654\u201364. https:\/\/doi.org\/10.1038\/s41391-023-00755-2.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07699-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:26:27Z","timestamp":1774401987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7699"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07699-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial or non-financial interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki (1964) and received approval from the Ethical Committee (n.339\/25, date: 18.06.2025).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study-specific approval by the appropriate ethics committee for research involving humans and\/or animals"}},{"value":"The informed consent was collected from all patients involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Data is available from the corresponding author uponreasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}